API PHARMA
The computed 12-month bankruptcy probability of API PHARMA is 2.2% (moderate). The 2024 annual accounts show equity of €37k and a net result of €35k. Its solvency ranks better than 72% of 6698 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €37k |
| Net result | €35k |
| Better than sector | 72% |
| Active | 2 yrs |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 45.8% | 20.4% | |
| Net result | €35k | €4k | |
| Equity | €37k | €16k | |
| Gross operating margin | €50k | €24k | |
| Total assets | €81k | €94k |
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €47k |
| Net profit | €35k |
| Cash flow | €37k |
| Staff costs | - |
| Income taxes | €10k |
| Dividends | €859 |
| Total assets | €81k |
| Equity | €37k |
| Debt | €44k |
| of which ≤ 1y | €33k |
| of which > 1y | €11k |
| Working capital | €25k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 1.76 |
| Quick ratio | 1.76 |
| Working capital ratio | 30.7% |
| Solvency | 45.8% |
| Debt / equity | 1.18 |
| Long-term debt ratio | 0.31 |
| Interest coverage | 170.46 |
| Gross margin | - |
| Net margin | - |
| ROA | 43.0% |
| ROE | 93.9% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €81k |
| Fixed assets | 21/28 | €24k |
| Tangible fixed assets | 22/27 | €24k |
| Current assets | 29/58 | €58k |
| Amounts receivable within one year | 40/41 | €11k |
| Cash & bank | 54/58 | €47k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €81k |
| Equity | 10/15 | €37k |
| Contributions / capital | 10/11 | €2k |
| Accumulated profits (losses) | 14 | €35k |
| Amounts payable | 17/49 | €44k |
| Amounts payable after one year | 17 | €11k |
| Amounts payable within one year | 42/48 | €33k |
| Trade debts payable within one year | 44 | €2k |
| Income statement | ||
| Gross operating margin | 9900 | €50k |
| Operating result | 9901 | €45k |
| Financial charges | 65 | €278 |
| Result before taxes | 9903 | €45k |
| Income taxes | 67/77 | €10k |
| Net result for the period | 9904 | €35k |
| Result to be appropriated | 9905 | €35k |
| NACE primary | Detailhandel in farmaceutische producten(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 18-09-2023 |
| Status | Active |
| Postal code | 4000 |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
25-03-2026 Registered office moved from TILFF to LIEGE
- 4130 TILFF (Esneux) - Rue de la Charrette 30 → 4000 LIEGE Boulevard Frère Orban, 34/5b
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "4000 LIEGE Boulevard Fr\u00E8re Orban, 34/5b",
"city": "LIEGE",
"region": "waals_gewest",
"street": "Boulevard Fr\u00E8re Orban",
"country": "BE",
"postcode": "4000",
"box_number": null,
"street_number": "34/5b",
"locality_suffix": null
},
"old_address": {
"raw": "4130 TILFF (Esneux) - Rue de la Charrette 30",
"city": "TILFF",
"region": "waals_gewest",
"street": "Rue de la Charrette",
"country": "BE",
"postcode": "4130",
"box_number": null,
"street_number": "30",
"locality_suffix": "(Esneux)"
},
"effective_date": "2026-03-03",
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "immediate",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2026-03-25",
"filing_date": "2026-03-16",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"date": "2026-03-03",
"unanimous": true
},
"subject_company": {
"kbo": "0805.949.739",
"name_full": "API PHARMA",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Alice PIRENNE",
"org_rep_person_name": null,
"person_role_at_subject": "Administrateur"
},
"co_filed_documents": [
"PV d\u0027OA"
]
}20-09-2023 Incorporation of a new SRL
Technical details
{
"kind": "oprichting",
"seat": "4130 Esneux (Tilff), Rue de la Charrette 30",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1999-04-15",
"name": "Madame PIRENNE Alice Emmanuelle Olivier Marie",
"niss": null,
"address": "4130 Esneux, Rue de la Charrette 30"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 2000,
"holder_person_name": "Madame PIRENNE Alice Emmanuelle Olivier Marie",
"is_subscriber_only": false,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 2000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 2000,
"subject_company": {
"kbo": "0805.949.739",
"name_full": "API PHARMA",
"legal_form": "SRL"
},
"initial_directors": [],
"incorporation_date": "2023-09-14",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | API PHARMA |